Here, we are going to share Lupin Ltd Share Price Target 2025 to 2040 on the basis of its fundamental and technical analysis.
Lupin Ltd is a well known pharmaceutical company headquartered in Mumbai, India.
It is one of the largest pharma companies in the country, known for manufacturing and marketing a broad range of generic and branded formulations, APIs, and biotechnology products.
With a global presence spanning over 100 countries, Lupin plays an important role in the healthcare industry.
Lupin Ltd Company Overview
- Established Year: 1968
- Headquarters: Mumbai, Maharashtra, India
- Business: Pharmaceutical manufacturing and distribution
- Growth: Lupin has grown into a global pharmaceutical player with strong market presence in key therapeutic areas and significant investments in research and development.
- Employees: Approximately 17,000
- Location: Operates in India, United States, Europe, and various other regions.
- Markets they serve: Lupin serves markets across India, North America, Europe, Japan, and emerging markets.
Lupin Ltd Share Key Information
| Company Name | Lupin Ltd |
| Headquarters | Mumbai, Maharashtra |
| Sectors | Pharmaceuticals & Drugs |
| Market Cap | ₹ 98,167.61 Cr. |
| No. of Shares | 45.61 Cr. |
| Book Value | ₹468.70 |
| Dividend Yield | 0.37% |
| ROCE | 14.33% |
| ROE | 12% |
| Face Value | ₹2 |
| Sales Growth | 30.27% |
| Profit Growth | 447.05% |
| Debt | ₹18.13 Cr |
| Cash | ₹138.64 Cr |
Lupin Ltd Business Sector
Lupin’s business model is centered around the development, manufacturing, and sale of a wide variety of generic and branded pharmaceuticals. It operates in several key areas:
- Generics: Lupin is a major player in the global generic drug market, providing cost-effective alternatives to branded drugs.
- Branded Formulations: The company also focuses on branded formulations, especially in markets like India and Japan.
- APIs: Active Pharmaceutical Ingredients (APIs) are a significant part of its portfolio, supplying both internal needs and external customers.
- Research and Development: Lupin invests heavily in R&D to innovate in areas such as biotechnology, biosimilars, and new chemical entities (NCEs).
Board Members
- Vinita Gupta: Chief Executive Officer
- Nilesh Gupta: Managing Director
- Kamlesh Shah: Independent Director
- Yashwant Mahadik: Independent Director
- Raghunandan Deshpande: Independent Director
- Manish Gupta: Non-Executive Director
Lupin Ltd Share Quarterly Results
| PARTICULARS | Mar 2024 | Jun 2024 |
|---|---|---|
| Net Sales | 3,395.88 | 4,167.63 |
| Total Expenditure | 2,695.53 | 2,968.82 |
| Operating Profit | 700.35 | 1,198.81 |
| Other Income | 31.34 | 39.08 |
| Interest | 13.49 | 13.55 |
| Depreciation | 290.04 | 141.42 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 428.16 | 1,082.92 |
| Tax | 44.08 | 193.74 |
| Profit After Tax | 384.08 | 889.18 |
| Adjusted EPS (Rs) | 8.43 | 19.50 |
Lupin Ltd Company Profits and Losses
| PARTICULARS | Mar 2023 | Mar 2024 |
|---|---|---|
| Net Sales | 11,258.83 | 14,666.50 |
| Total Expenditure | 10,294.93 | 11,227.12 |
| Operating Profit | 963.90 | 3,439.38 |
| Other Income | 210.02 | 126.41 |
| Interest | 98.44 | 56.35 |
| Depreciation | 548.34 | 724.75 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 527.14 | 2,784.69 |
| Tax | 101.93 | 458.60 |
| Net Profit | 425.21 | 2,326.09 |
| Adjusted EPS (Rs.) | 9.35 | 51.04 |
Lupin Ltd Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹2361 | ₹2465 |
| 2026 | ₹2485 | ₹2733 |
| 2027 | ₹2716 | ₹2976 |
| 2028 | ₹2950 | ₹3183 |
| 2029 | ₹3202 | ₹3502 |
| 2030 | ₹3525 | ₹3685 |
| 2035 | ₹4250 | ₹4890 |
| 2040 | ₹6250 | ₹7550 |
Lupin Ltd Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹2361 |
| February 2025 | ₹2368 |
| March 2025 | ₹2375 |
| April 2025 | ₹2379 |
| May 2025 | ₹2385 |
| June 2025 | ₹2392 |
| July 2025 | ₹2404 |
| August 2025 | ₹2412 |
| September 2025 | ₹2419 |
| October 2025 | ₹2433 |
| November 2025 | ₹2456 |
| December 2025 | ₹2465 |
Lupin Ltd Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹2485 |
| February 2026 | ₹2507 |
| March 2026 | ₹2534 |
| April 2026 | ₹2541 |
| May 2026 | ₹2550 |
| June 2026 | ₹2590 |
| July 2026 | ₹2587 |
| August 2026 | ₹2628 |
| September 2026 | ₹2674 |
| October 2026 | ₹2724 |
| November 2026 | ₹2732 |
| December 2026 | ₹2733 |
Lupin Ltd Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹2716 |
| February 2027 | ₹2739 |
| March 2027 | ₹2767 |
| April 2027 | ₹2774 |
| May 2027 | ₹2784 |
| June 2027 | ₹2824 |
| July 2027 | ₹2821 |
| August 2027 | ₹2858 |
| September 2027 | ₹2906 |
| October 2027 | ₹2958 |
| November 2027 | ₹2966 |
| December 2027 | ₹2976 |
Lupin Ltd Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹2950 |
| February 2028 | ₹2972 |
| March 2028 | ₹3002 |
| April 2028 | ₹3012 |
| May 2028 | ₹3058 |
| June 2028 | ₹3056 |
| July 2028 | ₹3093 |
| August 2028 | ₹3144 |
| September 2028 | ₹3190 |
| October 2028 | ₹3200 |
| November 2028 | ₹3199 |
| December 2028 | ₹3183 |
Lupin Ltd Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹3202 |
| February 2029 | ₹3237 |
| March 2029 | ₹3245 |
| April 2029 | ₹3251 |
| May 2029 | ₹3292 |
| June 2029 | ₹3290 |
| July 2029 | ₹3323 |
| August 2029 | ₹3423 |
| September 2029 | ₹3432 |
| October 2029 | ₹3465 |
| November 2029 | ₹3492 |
| December 2029 | ₹3502 |
Lupin Ltd Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹3525 |
| February 2030 | ₹3529 |
| March 2030 | ₹3548 |
| April 2030 | ₹3569 |
| May 2030 | ₹3578 |
| June 2030 | ₹3561 |
| July 2030 | ₹3582 |
| August 2030 | ₹3602 |
| September 2030 | ₹3612 |
| October 2030 | ₹3652 |
| November 2030 | ₹3665 |
| December 2030 | ₹3685 |
Lupin Ltd Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹4250 |
| April 2035 | ₹4456 |
| July 2035 | ₹4560 |
| October 2035 | ₹4750 |
| December 2035 | ₹4890 |
Lupin Ltd Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹6250 |
| April 2040 | ₹6480 |
| July 2040 | ₹6920 |
| October 2040 | ₹7120 |
| December 2040 | ₹7550 |
Lupin Ltd Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 46.98% |
| FIIs | 19.32% |
| DIIs | 26.78% |
| Others | 0% |
| Public | 6.92% |
Lupin Ltd Company Competitors
- Dr Reddy’s Lab
- Torrent Pharma
- Mankind Pharma
- Aurobindo Pharma
- Alkem Laboratories
Bull Case of Lupin Ltd (Reasons to Invest)
Strong Market Presence: Lupin has a robust presence in key markets like the United States and India, which contributes significantly to its revenue.
R&D Capabilities: Continuous investment in R&D is likely to lead to new product launches and expansion into new therapeutic areas.
Regulatory Approvals: Multiple regulatory approvals for new products can drive revenue growth.
Debt Management: Lupin has a strong balance sheet with low debt, making it financially stable.
Bear Case of Lupin Ltd (Risks Involved)
Regulatory Challenges: Frequent regulatory scrutiny and compliance issues can impact product launches and sales.
Competition: High competition in the generic drug market can pressure pricing and margins.
Dependence on Key Markets: Over-reliance on the U.S. market makes the company vulnerable to regulatory and pricing changes.
Currency Fluctuations: Global operations expose the company to currency risks, which can affect profitability.
Lupin Ltd Share Price Target: FAQ
What will be the target of Lupin Ltd Share for the year 2025?
By the end of the year 2025, its share price can reach ₹2465.
What will be the target of Lupin Ltd Share for the year 2026?
By the end of the year 2026, its share price can reach ₹2733.
What will be the target of Lupin Ltd Share for the year 2027?
By the end of the year 2027, its share price can reach ₹2976.
What will be the target of Lupin Ltd Share for the year 2028?
By the end of the year 2028, its share price can reach ₹3183.
What will be the target of Lupin Ltd Share for the year 2029?
By the end of the year 2029, its share price can reach ₹3502.
What will be the target of Lupin Ltd Share for the year 2030?
By the end of the year 2030 its share price can reach ₹3685.
What is the Current market cap of Lupin Ltd company?
At present the market cap of this company is ₹ 98,167.61 Cr.
What is the NSE symbol of Lupin Ltd company?
The symbol of this company in NSE exchange is LUPIN.
What is the BSE symbol of Lupin Ltd company?
The symbol of this company in BSE exchange is 500257.
